Modulation of glucagon receptor expression
US7399853B2 · kind B2 · utility
75Cited by
15References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2004 |
| Grant date | Jul 15, 2008 |
| Priority date | — |
| Expiry date | Feb 27, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/346
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise oligonucleotides, targeted to nucleic acid encoding glucagon receptor. Methods of using these compounds for modulation of glucagon receptor expression and for diagnosis and treatment of disease associated with expression of glucagon receptor are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.